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A b s t r a c t
The Warburg micro syndrome (WARBM) is a genetically heterogeneous syndrome linked to at least 4 loci. At the clin-
ical level, WARBM is characterized by microcephaly, microphthalmia, microcornea, congenital cataracts, corpus cal-
losum hypoplasia, severe mental retardation, and hypogonadism. In some families additional clinical features have 
been reported. The presence of uncommon clinical features (peripheral neuropathy, cardiomyopathy) may result in 
misdirected molecular diagnostics. Using the next generation sequencing approach (NGS), we were able to diagnose 
WARBM1 syndrome by detection of a  new mutation within the RAB3GAP1 gene. We have detected some DNA 
variants which may be responsible for cardiomyopathy. We did not find any obvious pathogenic mutation within 
a set of genes known to be responsible for hereditary motor and sensory neuropathy (HMSN). We conclude that: 
(i) in clinically delineated syndromes, a classical single-gene oriented approach may be not conclusive especially in 
the presence of rare clinical features, (ii) peripheral neuropathy and cardiomyopathy are rare additional symptoms 
coexisting with WARBM1, (iii) a pleiotropic effect of a single point mutation is sufficient to be causative for WARBM1 
and (iv) more WARBM-affected patients should be reported to delineate a complete phenotype. 
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Introduction
The Warburg micro syndrome (WARBM) is a very 
rare genetic disorder with an unknown frequency 
reported in a small group of patients (less than 100) 
around the world. 
For the first time in 1993, WARBM was reported in 
a consanguineous Pakistani marriage in three affect-
ed children with mental retardation [18]. In 2005, in 
turn, WARBM1 was linked to the 2q21.3 region, in 
which inactivating mutations within the RAB3GAP1 
gene were detected [2]. In recent years, access to 
molecular genetic analysis has made possible the 
delineation of the WARBM phenotype. WARBM man-
ifests with microcephaly, microphthalmia, microcor-
nea, congenital cataracts, corpus callosum hypopla-
sia, hypogonadism and severe mental retardation 
[6]. Two WARBM-affected sisters were also found to 
manifest peripheral neuropathy [11].
The vast majority of WARBM patients originate 
from consanguineous Muslim families [1,2,14]. 
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To date, four genes coding for RAB-family pro-
teins have been reported to be mutated in WARBM 
syndrome, i.e. the RAB3GAP1 gene on chromosome 
2q21.3 (MIM# 602536), RAB3GAP2 (MIM# 609275) 
on chromosome 1q41, the RAB18 gene (MIM# 
602207) located in the 10p12.1 region and final-
ly the TBC1D20 gene (MIM#611663) linked to the 
20p13 locus. At the clinical level, WARBM1-4 sub-
types are indistinguishable. 
To date, the analysis of WARBM-involved genes 
has been directed by the presence of typical clinical 
features. In fact, in previous studies, only a  single 
gene was analyzed and no data from the rest of the 
genome were available.
A question thus arises as to whether the whole 
clinical manifestation of WARBM is related to a sin-
gle mutation in one of the 4 RAB genes. 
In the work described here, we performed for the 
first time a whole-exome sequencing analysis in a Pol-




The patients were two sisters who died in the sec-
ond decade of life, being the only children of healthy, 
consanguineous (IV/V) parents (Fig. 1, Fig. 2A-C). They 
were born following uneventful pregnancies and deliv-
eries. The older girl weighed 2950 g, her body length 
was 56 cm, OFC was 35 cm, and the Apgar score was 
9 points. The younger girl weighed 2850 g, her body 
length was 54 cm, OFC was 32 cm, and the Apgar 
score was 10 points. Bilateral congenital cataract was 
apparent in both girls soon after birth, and a bilateral 
lentectomy was performed during their infancy. 
The girls were severely hypotonic from early life, 
and their psychomotor development was delayed. 
At the age of a few months, infantile spasms were 
observed in the younger sister. Electroencephalogra-
phy (EEG) showed hypsarrhythmia, so antiepileptic 
drugs were administered. Electroencephalography 
of the second sister was also severely abnormal, 
though no epileptic seizures were observed. 
At the age of 2 years they presented with cer-
ebellar ataxia. Limb and axial hypotonia were still 
observed, but a  bilateral Babinski sign was also 
detected. Mild microcephaly was visible in both girls 
from early childhood. 
Muscle biopsies performed at the ages of 1 and 
5 years in the two sisters showed only unspecific chang-
es in muscle fibers with mild lipid accumulation, and 
without any signs of myopathy or neurogenic chang-
es (data not shown). A biochemical study of OXPHOS 
revealed slightly decreased activity of complex I, but 
blood and cerebrospinal fluid lactate were normal, both 
at baseline and following glucose challenge.
In the second half of the first decade of the 
patients’ lives, mild spasticity developed, but tendon 
reflexes weakened progressively. Bilateral Babin ski 
signs were still detected, and skeletal anomalies 
related to chronic muscle hypotonia also developed, 
in the form of kyphoscoliosis, thoracic deformity, 
and joint contractures (ulnar, iliofemoral and of the 
knees). Hands were dropping and planovalgus feet 
were to be noted. Ophthalmological examination 
revealed microphthalmia, microcornea and pale, 
atrophic optic discs. Psychomotor retardation was 
marked. The patients were never able to sit and 
walk independently. The younger girl still had epilep-
tic seizures. The EEG of the second sister was also 
severely abnormal, but seizures were not observed. 
Fig. 1. Pedigree tree of the family. Note the common 
ancestor within the 1st generation in this consan-
guineous family tree. The proband is marked with 
an arrow. Open symbols indicate healthy males 
(squares) and females (circles). Filled symbols cor-
respond to affected individuals. Deceased individu-
als are marked with diagonal lines. The double line 
indicates consanguinity in this family.
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Brain MRI showed slowly progressive cortico-sub-
cortical cerebral and cerebellar atrophy as well as hypo-
myelination. The corpus callosum was thin and the 
brainstem was atrophic (Fig. 3). The Nerve Conduction 
Study (NCS) performed at 7 and 11 years, respective-
ly, revealed progressive motor and sensory neuro-
pathy, with demyelination and mildly expressed axonal 
degeneration. EMG showed neurogenic changes.
Both girls were of short stature, and deficient as 
regards body weight. The older girl was hypogonadal. 
The older girl had cardiomyopathy with left ventricu-
lar hypertrophy (148% of predicted muscle mass). Her 
arterial blood pressure was normal.
Molecular genetic analysis
This study was approved by the local Ethical Com-
mittee at the Cardinal Stephan Wyszynski University 
in Warsaw (3/2012 CSWUW). DNA isolated from the 
proband (VI.1) and her healthy parents (IV.3, V.1) was 
isolated from peripheral blood lymphocytes by the 
salting-out method, following receipt of the patients’ 
informed consent.
PCR and DNA sequencing
Initially, when we suspected the diagnosis of 
congenital cataracts, facial dysmorphism and neu-
ropathy (CCFDN), or Marinesco-Sjögren syndrome 
(MSS), we analysed the CTDP1 and SIL1 genes for 
mutations in the proband and her healthy parents. 
The 13 coding exons encompassing the intron-exon 
boundaries of the CTDP1 gene were amplified using 
the polymerase chain reaction (PCR) with previous-
ly reported primers [19]. The PCR products from the 
proband and her parents were sequenced directly 
using a  Dynamic terminator cycle sequencing kit 
(Applied Biosystems) on an ABI PRISM 3700 DNA 
analyzer (Applied Biosystems). To detect a  com-
mon CCFDN-causing mutation, i.e. the IVS6+389C>T 
Fig. 2. The patient (J.R.) at the age of 8 (A) and 
10 years (B). Note the dropping hands, thicken-
ing of the perioral tissue and anteriorly directed 
incisor teeth. C) Two sisters at the age of 4 and 
8 years. The same types of dysmorphic features 
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Fig. 3. Magnetic resonance imaging of the 
brain (T2-weighted) performed in patient 
M.R. at the age of 11 years. A) Cerebral atro-
phy and hypo/dysmyelination around lateral 
ventricles. B) Hypo/dysmyelination in the 
centrum semiovale. Decreased volume of 
white matter. C) Note the enlargement of 
the lateral ventricles and cerebral atrophy, 
especially around the frontal lobes. D) Note 
a  marked cerebellar atrophy and thin cor-
pus callosum resulting from the decreased 
white matter volume. E) Coronal section of 
the brain; note marked cerebellar atrophy, 
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mutation, a  restriction analysis with Nla III endo-
nuclease was performed using the forward primer: 
5’-CACTGTGTTAGCCAGGATGG-3’, and the reverse pri- 
mer: 5’-GTGCCGTCTGACAGAGATGA-3’. The SIL1 cod-
ing sequence was analysed by direct sequencing of 
the coding region.
Exome sequencing
Exome sequencing in the proband (VI.1) and 
parents (IV.3, V.1) was performed in line with the 
protocol from Illumina’s TruSeq Exome Enrichment 
Guide. The qualified genomic DNA was fragmented 
by Covaris, ligated with adapters, purified, amplified 
and hybridized using a Sure Select Human All Exon 
50 Mb Kit (Agilent Technologies), following the man-
ufacturer’s instructions. For enrichment, hybridized 
fragments were bound to the streptavidin beads, 
and non-hybridised fragments were washed out. 
The enriched library was then loaded on to a HiSeq 
2000 instrument (Illumina). Exome sequencing was 
performed by Intelliseq sp. z o.o., Cracow.
Exome sequence data analysis
The sequence reads were analysed using the 
Illumina pipeline (adapter sequences were removed 
and low-quality reads discarded). Reads were pro-
cessed by Picard, and aligned to a human reference 
sequence (GRCh37) using Bowtie2. BAM files were 
obtained for each sample using SAM tools, as well as 
by removing duplicate reads. SNP calling was then 
performed using GATK. To identify genes with reces-
sive inheritance (the parents are consanguineous 
[IV/V]), we filtered data by genotype (the proband 
as a homozygous alternative and the parents as het-
erozygous, two other control probes being used as 
a homozygous reference), before dbSNP annotation 
was carried out and common variants filtered for. 
The SIFT tool was used in the functional and conser-
vation prediction of SNPs. 
Mutation confirmation by Sanger 
sequencing
The coding sequence with the intron/exon boun-
daries of the 7th exon of the RAB3GAP1 gene was 
sequenced in family members by means of Sanger 
se quenc ing. Primers (Forward: 5’-CAGTTTGGTATTGT- 
AAGGAGAAA-3’ and Reverse: 5’-GCTAACAGACTGAAC- 
AAACAA-3’) were constructed on the basis of the 
NG_01697.1 genomic and NM_001172435.1 RNA 
sequences.
Analysis of other genes
To confirm a monogenic basis of the disease in 
our family we analysed NGS data for all variants in 
three other genes involved in Warburg micro syn-
drome diseases, i.e. RAB3GAP2 (NC_000001.11, NM_ 
012414.3), RAB18 (NC_000010.11, NM_021252.4) and 
TBC1D20 (NC_000020.11, NM_144628.3). 
Due to the occurrence of cardiomyopathy in one 
of the affected sisters, additional analysis of variants 
in 44 genes associated with cardiomyopathy was 
performed. Additionally, three genes essential in car-
diac homeostasis and mitochondrial fusion (MFN1 
– mitofusin 1, MFN2 – mitofusin 2 and OPA1 – optic 
atrophy 1) were analysed. 
We established a  list of genes on the basis of 
articles by J.M. Bos et al. 2009, A. Huertas-Vazquea 
et al. 2013, E. Villard et al. 2011, K. Stark et al. 2010, 
K.N. Papanicolaou et al. 2012 and Y. Chen et al. 2011 
[4,5,10,15,17,20].
Results
CTDP1 and SIL1 genes 
The IVS6+389C>T mutation in the CTDP1 gene 
was excluded by means of the RFLP analysis.
The sequencing of the entire CTDP1 coding se- 
 quence (including exon-intron boundaries) revealed 
two sequence variants. In the proband and her moth-
er, a  heterozygous C>T transition at position 1019 
resulting (by conceptual translation) in a Thr to Met 
amino-acid change at codon 340 (T340M) was identi-
fied in exon 7 of the CTDP1 gene. The T340M substi-
tution was not detected in the father of the proband. 
In the proband and her parents, a heterozygous tran-
sition G>A at position 2937 in the non-coding region 
was identified in exon 13 of the CTDP1 gene. Analysis 
of the SIL1 gene sequence did not reveal any DNA var-
iant which could be considered a pathogenic muta-
tion for Marinesco-Sjögren syndrome (MSS). 
Whole-exome sequencing 
Whole-exome analysis was performed in patient 1 
as well as in her healthy mother and father. DNA 
from patient 2 was not available for the study. After 
filtering for common variants (> 1%) present in the 
dbSNP database, we identified 155 variants of poten-
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tial importance. After filtering for nucleotide changes 
that potentially have a damaging effect on the protein 
and a high conservation ratio, we obtain only three 
variants among them, of which only one – c.538 G>T, 
p.E180X in the RAB3GAP1 gene – is suitable for the 
phenotype occurring in patients. Sanger sequencing 
confirmed the homozygous novel mutation in the 
proband and a heterozygous one in their healthy par-
ents. The remaining two homozygous variants that 
were found after filtering were: 
–  OR13C2 gene (olfactory receptor, family 13, sub-
family C, member 2) rs143198170, NC_0009.12: g. 
104605112_104605115delGTTA, NM_001004481.1: 
c. 513_516delTAAC, p. N171Kfs; 
–  CNOT1 (CCR4-NOT transcription complex, sub-
unit 1): rs5817153, NC_00016.10: g. 58543412delA, 
NM_016284.4: c. 4434+195delT (isoform a), NM_ 
206999.2 (isoform b): c. 4629delT, p. L1544Cfs, NM_ 
001265612.1: c. 4419+195delT (isoform c).
Analysis of other Warburg syndrome 
genes 
Analysis of other WARBM genes in the proband 
did not reveal any potentially pathogenic variants. 
But in the GAP3RAB2 gene a very rare homozygous 
variant rs2289189 g.220157863C>G (G allele frequen-
cy 0.059), c.3275G>C with heterozygosity of 0.111 was 
found, this being described in the dbSNP database as 
a benign polymorphism. 
Analysis of the genes involved  
in cardiomyopathy 
The analysis of genes associated with cardiomy-
opathy revealed many SNPs, from among which only 
rs365990 (g.23392602A>G; c.3302T>C; p.V1101A) 
in the MYH6 gene had been described previously as 
associated with a higher risk of cardiac conduction 
and rhythm disorders [4,9]. Moreover, a  very rare 
heterozygous benign polymorphism in the TTN gene 
called rs55842557 (g.178528964G>A  with allele A 
frequency of only 0.008, c.106787C>T, p.T35596I) 
was found. We identified that variant in the hete-
rozygous state in the proband and her mother, while 
no mutation was identified in her father. In the 
LDB3 gene, a  new variant discovered was c.1318 
T>C; p.S440P in VI.1, V.1 (heterozygous) and VI.3 
(homozygous), but due to the homozygous variant 
in the healthy father this mutation probably is not 
associated with cardiomyopathy occurred in VI.1. 
A  few missense benign polymorphisms, as well as 
numerous silent and intron mutations (not shown) 
were also found in other analysed genes.
Discussion
Surprisingly, even in the syndromes characterized 
by a  peculiar morphological phenotype, molecular 
diagnostics may be hampered by the presence of rare-
ly occurring symptoms. The peripheral demyelinating 
neuropathy and cardiomyopathy are not representa-
tive features of WARBM, however peripheral neuro-
pathy was previously reported in two affected sisters 
harboring mutation within the TBC1D20 gene [11].
Given the presence of peripheral neuropathy in 
our patients, we started molecular diagnostics from 
the syndromes in which peripheral neuropathy is 
a typical clinical feature.
At the beginning of our study we suspected 
a  diagnosis of congenital cataract facial dysmor-
phism neuropathy (CCFDN), or Marinesco-Sjögren 
syndrome (MSS). In a  classical phenotype-oriented 
gene analysis we have excluded the mutations with-
in the CTDP1 and SIL1 genes that are respectively 
causative for CCFDN and MSS.
Due to a lack of conclusive results using the clas-
sical Sanger sequencing approach, we decided to 
perform whole-exome sequencing analysis (WES) in 
this family.
It is an open question as to whether RAB3GAP1 
mutations alone are sufficient to result in a  com-
plete phenotype of WARBM1 patients. To the best 
of our knowledge, the WES analysis was not wide-
ly performed to date in WARBM patients. Thus, 
the potential impact of other genes has not been 
analyzed so far. Thus, given the large family of RAB 
proteins and RAB modulating factors, a  question 
arises in regard to the penetrance of the RAB3GAP1 
mutation. In fact, the patients detected by us man-
ifested with a complete phenotype of WARBM1. In 
the exome analysis we found only one deleterious 
RAB3GAP1 mutation; and no pathogenic mutations 
have been detected in other RAB and RAB-related 
genes. Thus, it is highly probable that a single point 
mutation within the RAB3GAP1 gene is the one and 
only cause of WARBM1 disease. This is especially the 
case given that mutations in the RAB3GAP1 gene 
associated with WARBM1 were described in fam-
ilies of very varied ethnic origin, with the number 
of mutations identified already exceeding 50 [14]. 
The clinical picture of the WARBM1 in our patients 
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corresponds with the phenotype described by oth-
er authors [7]. However, not typically, in our patients 
peripheral demyelinating motor-sensory polyneu-
ropathy and cardiomyopathy were identified. 
Interestingly, in a  series of WARBM individu-
als with TBC1D20 mutations, only two sisters were 
found to have demyelinating polyneuropathy [11]. 
The occurrence of peripheral demyelinating neuro-
pathy within WARBM-affected patients is hard to 
estimate, since only in some have electromyographic 
investigations been reported.
 In the whole-exome approach used in this study, 
we did not find any obvious deleterious mutations in 
the genes involved in the molecular pathogenesis of 
hereditary motor and sensory neuropathies (HMSN). 
Thus, due to a  lack of mutations within known 
HMSN genes, we tend to consider peripheral neu-
ropathy rather as a part of the WARBM1 phenotype 
than an additional clinical feature associated with 
a mutation of another gene (overlapping syndrome). 
Cerebral and cerebellar atrophy, as well as hypo-
plasia of the corpus callosum seem to be hallmarks 
of WARBM [3,6,13]. In our patients too, it was pos-
sible to observe cerebral and cerebellar atrophy with 
hypoplasia of the corpus callosum. The former sign is 
a typical finding connected with, and resulting from, 
hypomyelination. The patients reported by us died 
in the second decade of life. The nonsense E180X 
mutation in the RAB3/GAP1 mutation may be at 
least partially responsible for the poor clinical out-
come in these patients. 
In one of our patients, cardiomyopathy with left 
ventricular hypertrophy was detected. Since early- 
onset hypertrophic cardiomyopathy is often asso-
ciated with the mutation of one of the sarcomere 
genes, we decided to screen the most often mutated 
genes using an exome approach. We did not detect 
any pathogenic mutation for the hypertrophic car-
diomyopathy. It only proved possible to detect one 
heterozygous benign polymorphism – rs365990 in 
the MYH6 gene – this being previously described as 
associated with a high risk of cardiac conduction and 
rhythm disorders [4,8,9]; as well as the heterozygous 
rare polymorphism rs55842557 in the TTN gene. 
Moreover, polymorphism c.1924-851A>G (rs6730157) 
in the RAB3GAP1 gene has been recently described 
as being associated with effects on total cholesterol 
and high density lipoprotein cholesterol levels, and 
with an increased risk of sudden cardiac death [12].
For this reason, it is not definitively possible to 
preclude hypertrophic cardiomyopathy belonging to 
the WARBM syndrome phenotype.
Recently, in the consanguineous family with 
Kurdish-Armenian descent a  large deletion encom-
passing exons 4-15 of the RAB3GAP1 gene has been 
found in the siblings with the WARBM1 syndrome. 
Interestingly, in this pair of patients a mild growth 
hormone deficiency was detected, and X-ray exam-
ination revealed severe osteopenia, which have been 
not detected to date in WARBM [16]. For molecular 
diagnostic purposes, the lack or presence of some 
atypical symptoms should not preclude the molecu-
lar analysis of the RAB genes. Moreover, due to a lim-
ited number of reported patients, the frequency of 
WARBM-associated symptoms could not be estimat-
ed. Noteworthy, clinical variability of WARBM in var-
ious age-groups of patients is also unknown. Thus, 
a minimal set of symptoms which are necessary for 
WARBM diagnosis and decision concerning molecu-
lar diagnostics may be misleading. 
In fact, the number of WARBM reported patients 
is still too low for reliable phenotype-genotype cor-
relations to be derived. 
To summarize, the patients reported by us man-
ifest with a severe clinical form of WARBM1 associ-
ated with peripheral demyelinating neuropathy and 
cardiomyopathy. 
Due to the unique structure of the family tree 
in this study (a  recessive trait of inheritance and 
a detected common ancestor in the 6th generation), 
we were able to prioritize the filtering process in the 
interpretation of the exome data. The exome analy-
sis identified only three probably important homozy-
gous sequence variants in the proband. Additionally, 
only one sequence variant was detected in the RAB-
3GAP1 gene whose mutations had been shown pre-
viously to segregate with the phenotype of WARBM. 
Finally, by means of conceptual translation, the iden-
tified sequence variant within the RAB3GAP1 gene 
resulted in a  homozygous nonsense E180X muta-
tion truncating the RAB3GAP1 protein. Our study 
confirms the usefulness of WES analysis in the ped-
igrees with an evident recessive trait of inheritance 
and evidence of the common ancestor in the family. 
Because of the non-specificity of signs and symp-
toms of many disorders, molecular genetics is indis-
pensable in establishing a specific diagnosis. In fact, 
exome analysis seems to be very serviceable in cas-
es of unknown background. Whole-exome sequenc-
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ing in our family gives a  chance for the battery of 
biochemical, imaging and other tests to be omitted. 
In fact, exome analysis is a cost- and time-effective 
approach. Most importantly, it also reduces the dis-
comfort of affected patients associated with a long 
diagnostic process. 
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